In one such study, niaid researchers working ...

Pneumonia. pneumonia can infect the upper and can spread to, or. Pneumococcal pneumonia primarily causes illness in children younger than 2 years and adults aged 65 and older. Older people, especially at risk of getting seriously ill and dying from this disease. Also, people with certain diseases such as chronic heart, lung or liver, or

also are at increased risk for pneumococcal pneumonia. People with infections

, or people who have had organ transplants and take medicines that lower their resistance to infection and high risk of getting this

pneumonia can be caused by different, and sometimes. Pneumococcal pneumonia is the bacterium called. S. pneumonia

also called pneumococcus. Pneumococcus spreads through strattera 40mg contact between people who are sick or carrying the bacteria in the throat. You can get pneumococcal pneumonia from airborne droplets from the nose or mouth of an infected person. It is common for people, especially children, to hold the bacteria in the throat without being sick. Pneumococcal pneumonia may begin suddenly. You can initially difficult sotryasayuschyy fever is usually accompanied by high << Other >> and germs can also cause pneumonia. So if you have symptoms of pneumonia, you should be early diagnosis and start taking medication, if necessary. Your doctor usually can diagnose pneumococcal pneumonia by finding S. pneumonia

bacteria in your, or lung fluid. Your doctor usually appointed to treat this disease. The symptoms of pneumococcal pneumonia usually disappear within 12 to 36 hours after the medication. Some bacteria, such as S.pneumoniae, however, being able to resist and fight with antibiotics. Such resistance to antibiotics is increasing worldwide because these medicines are abused or incorrectly. So if you are at risk of getting pneumococcal pneumonia, you should talk with your doctor about what you can do to prevent this. Pneumococcal vaccine is the only way to prevent getting pneumococcal pneumonia. Vaccines for children and adults. Vaccines and immunization recommends that you get pneumococcal pneumonia vaccine if you are in one of these groups. Do you have a serious long term health problems such as heart disease, sickle cell anemia, alcoholism, lung disease (excluding asthma), diabetes, cirrhosis or

or, or other types of cancer

body or damaged NIP recommends that all babies and children under 2 years get pneumococcal vaccine. Consult your doctor to find out whether you or your child should be vaccinated to prevent pneumococcal pneumonia. Approximately 30 percent of people with pneumococcal pneumonia, the bacteria penetrate the blood from the lungs. This leads to bacteremia, a serious complication of pneumococcal pneumonia, which can also cause other problems easy and some heart problems. National Institute of Allergy and Infectious Diseases (NIAID) supports research on more effective prevention and treatment approaches to combat pneumonia and its causes, including research

NIAID has made an important contribution to the development of conjugated pneumococcal vaccine for children. This vaccine helps prevent pneumococcal disease in infants and toddlers is the latest achievement in the development of vaccines against common bacterial infections. NIAID supports research on the development and evaluation of improved pneumococcal vaccines for children worldwide. In one such study, NIAID researchers working with the Government of the Gambia (a country in West Africa) as well as scientists from several international research institutions to test the vaccine, conjugated pneumococcal. Health experts consistently identified pneumococcus as the most common cause of bacterial pneumonia in the Gambia. In the pattern typical of many regions, infant and child mortality in the Gambia are high, acute respiratory infections are the leading cause of death, and pneumococcus is the most common cause of these infections. Results of four-year randomized controlled clinical trials showed the vaccine reduced infant mortality by 16 per cent of children who received pneumococcal conjugated vaccine. The vaccine was 77 percent effective in preventing infections caused by vaccine serotypes. For more information about this study online [/ research / topics / bacterial / clinical / Gambia / GambiaPneumococcalVaccineTrial. HTM pneumococcal vaccine Gambia Trial]. 31 Center Drive, MSC 2292

Bethesda, MD 20892

Bethesda, MD 20894

1600 Clifton Road, ST, Mailstop E-05

Atlanta, GA 30333

New York, NY 10019

4733 Bethesda Avenue, Suite 750

Bethesda, MD 20814-5228.